European Leukemia Trial Registry
Trial: CINC424A2104 (HARMONY)

More Details
Title Phase I trial on Ruxolitinib in combination with BKM120 in patients with PMF, PPV-MF and PET-MF
Scientific Title A Phase Ib, Open-label, Multi-center, Two-arm, Dose-finding Study to Assess Safety and Efficacy of the Oral Combination or INC424 (INC424) and BKM120 in Patients With Primary Myelofibrosis (PMF), Postpolycythemia Vera-myelofibrosis (PPV-MF), or Post-essential Thrombocythemia-myelofibrosis (PET-MF)
Short Title CINC424A2104 (HARMONY)
Trialgroup NN
Type of Trial multicentric, prospective, open-label, double-group
Disease Myeloproliferative disease(MPD) Myelofibrosis
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.12.2012
Shortprotocol Shortprotocol
created 21.01.2014 Johannes Kraus
changed 01.06.2015 Hanna Ebert
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org